Hester Biosciences Limited
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more
Hester Biosciences Limited (HESTERBIO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.050x
Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has a cash flow conversion efficiency ratio of 0.050x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹174.78 Million) by net assets (₹3.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hester Biosciences Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Hester Biosciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hester Biosciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hester Biosciences Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762
|
0.035x |
|
Petra Diamonds Limited
PINK:PDLMF
|
-0.150x |
|
SIFCO Industries Inc
NYSE MKT:SIF
|
0.209x |
|
Heungkuk F&M I
KO:000540
|
0.097x |
|
Sajodongaone Co Ltd
KO:008040
|
0.045x |
|
Suria Capital Holdings Bhd
KLSE:6521
|
-0.009x |
|
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA
|
-0.145x |
|
Joinsoon Electronics MFG Co Ltd
TWO:3322
|
0.029x |
Annual Cash Flow Conversion Efficiency for Hester Biosciences Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Hester Biosciences Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹3.27 Billion | ₹645.11 Million | 0.197x | +24.27% |
| 2024-03-31 | ₹3.03 Billion | ₹481.34 Million | 0.159x | +96.92% |
| 2023-03-31 | ₹2.92 Billion | ₹235.96 Million | 0.081x | +145.00% |
| 2022-03-31 | ₹2.67 Billion | ₹88.08 Million | 0.033x | -86.61% |
| 2021-03-31 | ₹2.36 Billion | ₹580.53 Million | 0.246x | +32.67% |
| 2020-03-31 | ₹2.06 Billion | ₹382.92 Million | 0.185x | -30.32% |
| 2019-03-31 | ₹1.81 Billion | ₹482.10 Million | 0.266x | +1.48% |
| 2018-03-31 | ₹1.45 Billion | ₹380.24 Million | 0.262x | -6.41% |
| 2017-03-31 | ₹1.24 Billion | ₹347.98 Million | 0.280x | +51.04% |
| 2016-03-31 | ₹1.05 Billion | ₹194.44 Million | 0.186x | -34.69% |
| 2015-03-31 | ₹838.58 Million | ₹238.21 Million | 0.284x | +129.46% |
| 2014-03-31 | ₹762.88 Million | ₹94.44 Million | 0.124x | -26.51% |
| 2013-03-31 | ₹684.95 Million | ₹115.37 Million | 0.168x | -27.37% |
| 2012-03-31 | ₹610.60 Million | ₹141.61 Million | 0.232x | -14.56% |
| 2011-03-31 | ₹479.85 Million | ₹130.26 Million | 0.271x | -18.64% |
| 2010-03-31 | ₹408.64 Million | ₹136.33 Million | 0.334x | +57.34% |
| 2009-03-31 | ₹366.47 Million | ₹77.71 Million | 0.212x | -27.97% |
| 2008-03-31 | ₹334.69 Million | ₹98.53 Million | 0.294x | -30.04% |
| 2007-03-31 | ₹279.47 Million | ₹117.60 Million | 0.421x | +225.91% |
| 2006-03-31 | ₹136.48 Million | ₹17.62 Million | 0.129x | -- |